Control of Peripheral Nerve Myelination by the ß-Secretase BACE1

Michael Willem(Amgen (United States)), Alistair N. Garratt(Amgen (United States)), Božidar Novak(Amgen (United States)), Martin Citron(Amgen (United States)), Steve Kaufmann(Amgen (United States)), Andrea Rittger(Amgen (United States)), Bart De Strooper(Amgen (United States)), Paul Säftig(Amgen (United States)), Carmen Birchmeier(Amgen (United States)), Christian Haass(Amgen (United States))
Science
September 21, 2006
Cited by 686

Abstract

Although BACE1 (beta-site amyloid precursor protein-cleaving enzyme 1) is essential for the generation of amyloid-b peptide in Alzheimer's disease, its physiological function is unclear. We found that very high levels of BACE1 were expressed at time points when peripheral nerves become myelinated. Deficiency of BACE1 resulted in the accumulation of unprocessed neuregulin 1 (NRG1), an axonally expressed factor required for glial cell development and myelination. BACE1-/- mice displayed hypomyelination of peripheral nerves and aberrant axonal segregation of small-diameter afferent fibers, very similar to that seen in mice with mutations in type III NRG1 or Schwann cell-specific ErbB2 knockouts. Thus, BACE1 is required for myelination and correct bundling of axons by Schwann cells, probably through processing of type III NRG1.


Related Papers

No related papers found

Powered by citation graph analysis